Home / Investor Library / HealthShares in the News / HealthShares Announces Change to the HealthShares™ Ophthalmology Index

HealthShares in the News

04.09.2007

HealthShares Announces Change to the HealthShares™ Ophthalmology Index
New York (April 9, 2007) – HealthShares™ Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor’s, the calculating agent for the HealthShares™ Ophthalmology Index, that effective at the opening of trading on Thursday April 12, 2007, Watson Pharmaceuticals Inc. (NYSE:WPI) will replace Biogen Idec Inc. (Nasdaq: BIIB) in the HealthShares™ Ophthalmology Index. Companies included in the Ophthalmology Index are engaged in the research, clinical development and/or commercialization of therapeutic agents by means of pharmaceuticals, medical devices or biomaterials for the treatment of various diseases of the eye.

HealthShares Announces Change to the HealthShares™ Ophthalmology Index


<< back to news